FDA Investigator Anthony A Charity

Anthony A Charity has conducted inspections on 48 sites in 13 countries as of 15 Jul 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
48
Last Inspection Date:
15 Jul 2013
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, China, Netherlands, France, United Kingdom of Great Britain and Northern Ireland, Australia, Italy, Mexico, India, Germany, South Africa, Korea (Republic of), Spain
FDA Investigators that have inspected at least one site in common with Anthony A Charity:
Alan M Barker, Amy N Chen, Ana P Pineda Zavaleta, Anastasia M Shields, Anissa M Vargas, Anita R Michael, Ann Marie Karnick, Anne M Pilaro, Anthony C Warchut, Arie C Menachem, Arnold Seo, PhD, Arsen Karapetyan, Atul J Agrawal, Audrey Thereset Uy, Azza Talaat, Barbara J Rincon, Bonita S Chester, Brian D Young, Cara M Minelli, CDR Ileana Barreto Pettit, Charanjeet Jassal, Charles M Edwards, Charles R Cote, RIC, Cheryl A Clausen, Chiang Syin, PhD, Colleen M Damon, Constantin Y Philopoulos, Craig D Zagata, Daniel P Becker, Daniel R Tammariello, Darren S Brown, David A Oluwo, David J Hafner, Debra J Bennett, Debra L Pagano, Denise M Digiulio, Dennis Cantellops Paite, Dipesh K Shah, Donald L Lech, Douglas A Campbell, Dr. Gerald E Poly, Dr. Mark J Seaton, PhD, Edward D Mcdonald, Edwin Martinez, Edwin Melendez, Elena Karnaukhova, PhD, Eric M Mueller, PharmD, Erika V Butler, Farhana Khan, Frank W Perrella, Gayle S Lawson, George Pyramides, Geraldine D Sanders, Gwyn G Dickinson, H Ljamilla Selby, Hala L Selby, Hala Lj Whetstone, Hamet M Toure, PharmD MPH, Heriberto Negron Rivera, Jai P Singh, James D Planchon, James M Mason, James P Mcevoy, Javier E Santos, Jeen S Min, Joanne M Schlossin, Joel D Hustedt, John D White, Jonathan W Chapman, Jorge L Guadalupe, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Jose R Hernandez, Joseph Brady, Joseph L Despins, PhD, Joseph T Dougherty, Joshua P Wireman, Juanita P Versace, Julianne C Mccullough, Junho Pak, Justin A Boyd, Kara D Dobbin, Karen Takahashi, Karl D Hezel, Karthik B Iyer, Karyn M Campbell, Katherine Szestypalow, Kelly N Kerr, Kendra L Brooks, Kenneth M Gordon, Kent C Faul, Kevin A Gonzalez, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kimberley A Hoefen, Ko U Min, Kristen D Evans, Kristina J Donohue, Kristina Mjoyce Pittman, Kristy A Zielny, Laurie B Frazier, Laurie Nelson, Laurimer Kuilan Torres, LCDR Debra Emerson, LCDR Susan E Polifko, Lisa Shin, Lloyd D Payne, Lourdes Valentin Aponte, Lucas B Leake, Luis A Carrion, Luis A Dasta, Luis Mburgos Medero, Madushini Dharmasena, PhD, Marc A Jackson, Jr, Margaret M Annes, Maria A Reed, Marianela Aponte Cruz, Marie F Morin, Marisol Faberlle, Marvin D Jones, Mary Davis Lopez, Mary E Storch, Massoud Motamed, Matthew B Casale, Matthew R Noonan, Meisha R Sampson, Meisha Waters, Michael A Charles, Michael A Taylor, Michael C Rogers, Michael F Skelly, PhD, Michael Gurbarg, Michael P Sheehan, Michael R Goga, Michele L Obert, Michele M Falchek, Michele Perry Williams, Mike M Rashti, Mra Mcculloughj, Mra Munizn, Nancy G Schmidt, Nicholas A Violand, Nicholas L Hunt, Nicole E Knowlton, Nicole K Trudel, Niketa Patel, Nikhil Thakur, Nikisha M Bolden, Patricia H Dlugosz, Patrick L Wisor, Paul L Bellamy, Paul Mouris, Peter E Baker, Phillip Angart, PhD, Prabhu P Raju, Pratik S Upadhyay, DDC, Rabin N Ghoshal, Rafael Nevarez Nieves, Rakhi B Shah, Ralph H Vocque, Raquel Gonzalez Rivera, Reba A Gates, Reyes Candau Chacon, PhD, Richard Heath Coats, Robert B Shibuya, MD, Robert C Coleman, Robert J Maffei, Robin P Mathew, Rochelle K Kimmel, Rochelle L Cross, Roger F Zabinski, Rose Ljean Mary, Rozelle G Smith, Saied A Asbagh, Saleem A Akhtar, Sam Pepe, Samuel T Walker, Sandra A Hughes, Santiago Gallardo Johnson, Sarah E Mcmullen, Sarah K Graham, Satheesh Thomas, Shirley J Berryman, Simone E Pitts, Stephanie Mangigian, MS/OSH, RN, Stephen J Koniers, Steven B Hertz, Steven C Madzo, Steven D Kehoe, Steven E Kane, Steven M Weinman, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susan T Hadman, Susan W Ting, Susanna E Ford, Tamil Arasu, PhD, Tammy L Chavis, Tara G Bizjak, Tara R Gooen, Ted L Anderson, Tekalign Wondimu, Temar Q Williams, Teresa I Navas, Terri L Dodds, Thomas E Friel, Thomas J Arista, Tiffani D Wilson, Truong Xuan Nguyen (Andy), Van Cliff, Vlada Matusovsky, Wayne D Mcgrath, Wayne T Smith, William J Leonard, Yumi J Hiramine, Yvette I Henry, Yvette I Johnson, Yvonne C Mcknight, Yvonne C Wood, Zachary A Bogorad, Zedong Dong, Zhongren Wu

Anthony A Charity's Documents

Publish Date Document Type Title
February, 2013 EIR SRIKEM LABORATORIES PRIVATE LIMITED - EIR, 2013-02-15
March, 2013 FDA 483 COSMA Spa - Form 483, 2013-03-22
May, 2000 EIR SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. - EIR, 2000-05-10
March, 2013 EIR COSMA Spa - EIR, 2013-03-22
February, 2013 FDA 483 SRIKEM LABORATORIES PRIVATE LIMITED - Form 483, 2013-02-15
May, 2000 EIR Pucheng Chia Tai Biochemistry Co., Ltd. - EIR, 2000-05-17
March, 2000 EIR Calvert Laboratories, Inc. - EIR, 2000-03-07
March, 2012 EIR Industrias Químicas Falcón de México, S.A. de C.V. - EIR, 2012-03-30
April, 2013 EIR Alembic Pharmaceuticals Limited - EIR, 2013-04-18
March, 2000 FDA 483 Calvert Laboratories, Inc. - Form 483, 2000-03-07
May, 2013 EIR SKYEPHARMA PRODUCTION SAS - EIR, 2013-05-31
April, 2013 FDA 483 Alembic Pharmaceuticals Limited - Form 483, 2013-04-18
March, 2000 FDA 483 Response Institute for Human Gene Therapy - Form 483R, 2000-03-01
May, 2013 EIR Moehs Catalana SL - EIR, 2013-05-09
November, 2000 FDA 483 Response Abbott Biologicals BV - Form 483R, 2001-02-02
November, 2000 EIR Abbott Biologicals BV - EIR, 2000-11-02
April, 2013 EIR N.V. Organon - EIR, 2013-04-05
March, 2012 FDA 483 Industrias Químicas Falcón de México, S.A. de C.V. - Form 483, 2012-03-30
May, 2000 FDA 483 Pucheng Chia Tai Biochemistry Co., Ltd. - Form 483, 2000-05-17
May, 2000 FDA 483 Response Kprea Otsuka Pharmaceutical Co. - Form 483R, 2000-08-24
May, 2013 FDA 483 Moehs Catalana SL - Form 483, 2013-05-09
July, 2013 EIR Alphapharm Pty Ltd - EIR, 2013-07-18
March, 2000 EIR Institute for Human Gene Therapy - EIR, 2000-03-01
May, 2000 EIR Kprea Otsuka Pharmaceutical Co. - EIR, 2000-05-05
October, 2000 FDA 483 Solvay Pharmaceuticals - Form 483, 2000-10-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more